Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)
- Status
- COMPLETED
- Phase
- PHASE3
Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole
- Status
- COMPLETED
- Phase
- PHASE3
The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration
- Status
- TERMINATED
- Phase
- PHASE2
Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery
- Status
- WITHDRAWN
- Phase
- PHASE2
Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal
- Status
- TERMINATED
- Phase
- PHASE2
Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus in Treating Patients With Recurrent Low-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
RAD001(Everolimus) in Treating Patients With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2
RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A
- Status
- COMPLETED
- Phase
- PHASE2
CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial
- Status
- COMPLETED
- Phase
- PHASE3
Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3